Understanding COVID-19-associated coagulopathy
EM Conway, N Mackman, RQ Warren… - Nature Reviews …, 2022 - nature.com
Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …
A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and …
The COVID-19 pandemic has created significant concern for everyone. Recent data from
many worldwide reports suggest that most infections are caused by the Omicron variant and …
many worldwide reports suggest that most infections are caused by the Omicron variant and …
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, multiple severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
[HTML][HTML] Omicron variant (B. 1.1. 529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
M Dhawan, ARA Saied, S Mitra, FA Alhumaydhi… - Biomedicine & …, 2022 - Elsevier
Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …
[HTML][HTML] Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Lipid nanoparticles (LNPs) have been one of the most successful nano-delivery vehicles
that enable efficient delivery of cytotoxic chemotherapy agents, antibiotics, and nucleic acid …
that enable efficient delivery of cytotoxic chemotherapy agents, antibiotics, and nucleic acid …
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Recently, a large number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) variants continuously emerged and posed a major threat to global public health. Among …
2) variants continuously emerged and posed a major threat to global public health. Among …
Update on the omicron sub‐variants BA. 4 and BA. 5
TE Tallei, S Alhumaid, Z AlMusa… - Reviews in medical …, 2023 - Wiley Online Library
Several nations have recently begun to relax their public health protocols, particularly
regarding the use of face masks when engaging in outdoor activities. This is because there …
regarding the use of face masks when engaging in outdoor activities. This is because there …
[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence
R Nevola, R Ruocco, L Criscuolo, A Villani… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …
are constantly increasing. Despite the availability of potentially curative treatments (liver …
COVID-19 vaccines adverse events: potential molecular mechanisms
M Lamprinou, A Sachinidis, E Stamoula, T Vavilis… - Immunologic …, 2023 - Springer
COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …
SARS‐CoV‐2 Omicron and its current known unknowns: A narrative review
TTB Le, T Vasanthakumaran… - Reviews in medical …, 2023 - Wiley Online Library
The emergence of the SARS‐CoV‐2 Omicron variant (B. 1.1. 529) has created great global
distress. This variant of concern shows multiple sublineages, importantly B. 1.1. 529.1 (BA …
distress. This variant of concern shows multiple sublineages, importantly B. 1.1. 529.1 (BA …